The two countries already are working together behind the scenes. Michael Pillsbury, a senior fellow at the Hudson Institute who advises the Trump administration on China, pointed to efforts underway by the American biotechnology companies Inovio Pharmaceuticals, GeoVax and Gilead Sciences to develop a coronavirus treatment in China, some in partnership with Chinese companies.
Hudson Institute analyst Michael Pillsbury, who informally advises Trump on China and trade, said he does not view Trump's stepped up rhetoric about the "Chinese virus" as signaling that the president is ready to dramatically escalate tensions with Beijing.
But Michael Pillsbury, a China expert at the conservative Hudson Institute who informally advises the White House on economic issues, said Trump had chosen not to “rise to the bait.”
Michael Pillsbury, a China expert at the Hudson Institute who advises the Trump administration, said he supported the emergency measures and that they might be escalated based on the situation.